Pharming Group N.V. - ADS, each representing 10 ordinary shares (PHAR)
8.9250
+0.1250 (1.42%)
Pharming Group N.V. is a biotechnology company focused on the development and commercialization of innovative therapeutic products using its proprietary expertise in protein and gene technology
The company is primarily dedicated to creating advanced treatments for rare genetic diseases and other medical conditions, leveraging its specialized capabilities in recombinant protein production. Pharming's flagship product is designed to provide effective therapies that improve the quality of life for patients with unmet medical needs, demonstrating a commitment to research and development in the biopharmaceutical field.
